Ligong Lu

211 papers and 4.8k indexed citations i.

About

Ligong Lu has authored 211 papers that have received a total of 4.8k indexed citations. This includes 63 papers in Molecular Biology, 60 papers in Hepatology and 46 papers in Oncology. The topics of these papers are Hepatocellular Carcinoma Treatment and Prognosis (54 papers), Nanoplatforms for cancer theranostics (31 papers) and Cancer Mechanisms and Therapy (20 papers). Ligong Lu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (54 papers), Nanoplatforms for cancer theranostics (31 papers) and Cancer Mechanisms and Therapy (20 papers) and collaborates with scholars based in China, United States and Macao. Ligong Lu's co-authors include Meixiao Zhan, Xu He, Bao‐Shan Hu and Sirui Fu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Medicine

In The Last Decade

Rankless by CCL
2025